Ethanolic extract of Condurango (Marsdenia condurango) used in traditional systems of medicine including homeopathy against cancer can induce DNA damage and apoptosis in non small lung cancer cells, A549 and H522, in vitro
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
In traditional systems of medicine including homeopathy, the Condurango extract (Con) is often used to cure stomach cancer mainly, without having any scientific validation of its anti-cancer ability. Con has therefore been tested against non-small-cell lung cancer cells (NSCLC) A549 and NCI-H522 (H522) known to contain the KRAS mutation, making them resistant to most chemotherapeutic agents. As cancer cells generally defy cytotoxicity developed by chemopreventive agents and escape cell death, any drug showing the capability of preferentially killing cancer cells through apoptosis is worth consideration for judicious application. A549 and H522 cells were exposed to 0.35 µg/µl and 0.25 µg/µl of Con, respectively, for 48 h and analysed based on various protocols associated with apoptosis and DNA damage, such as MTT assay to determine cell viability, LDH assay, DNA fragmentation assay, comet assay, and microscopical examinations of DNA binding fluorescence stains like DAPI, Hoechst 33258 and acridine orange/ethidium bromide to determine the extent of DNA damage made in drug-treated and untreated cells and the results compared. Changes in mitochondrial membrane potential and the generation of reactive oxygen species were also documented through standard techniques. Con killed almost 50% of the cancer cells but spared normal cells significantly. Fluorescence studies revealed increased DNA nick formation and depolarized membrane potentials after drug treatment in both cell types. Caspase-3 expression levels confirmed the apoptosis-inducing potential of Con in both the NSCLC lines. Thus, overall results suggest considerable anticancer potential of Con against NSCLC in vitro, validating its use against lung cancer by practitioners of traditional medicine including homeopathy.
Abstract
In traditional systems of medicine including homeopathy, the Condurango extract (Con) is often used to cure stomach cancer mainly, without having any scientific validation of its anti-cancer ability. Con has therefore been tested against non-small-cell lung cancer cells (NSCLC) A549 and NCI-H522 (H522) known to contain the KRAS mutation, making them resistant to most chemotherapeutic agents. As cancer cells generally defy cytotoxicity developed by chemopreventive agents and escape cell death, any drug showing the capability of preferentially killing cancer cells through apoptosis is worth consideration for judicious application. A549 and H522 cells were exposed to 0.35 µg/µl and 0.25 µg/µl of Con, respectively, for 48 h and analysed based on various protocols associated with apoptosis and DNA damage, such as MTT assay to determine cell viability, LDH assay, DNA fragmentation assay, comet assay, and microscopical examinations of DNA binding fluorescence stains like DAPI, Hoechst 33258 and acridine orange/ethidium bromide to determine the extent of DNA damage made in drug-treated and untreated cells and the results compared. Changes in mitochondrial membrane potential and the generation of reactive oxygen species were also documented through standard techniques. Con killed almost 50% of the cancer cells but spared normal cells significantly. Fluorescence studies revealed increased DNA nick formation and depolarized membrane potentials after drug treatment in both cell types. Caspase-3 expression levels confirmed the apoptosis-inducing potential of Con in both the NSCLC lines. Thus, overall results suggest considerable anticancer potential of Con against NSCLC in vitro, validating its use against lung cancer by practitioners of traditional medicine including homeopathy.
참고문헌 (29)
- Banerji P, "Cancer patients treated with the Banerji protocols utilising homoeopathic medicine: A best case series program of the National Cancer Institute USA", Oncol Rep, 20, pp.69~74 (2008)
- Biswas R, "Thujone-rich fraction of Thuja occidentalis demonstrates major anti-cancer potentials: evidences from in vitro studies on A375 cells", Evid Based Complement Alternat Med, 2011, pp.568148~ (2011)
- Bolduc S, "Cadmium-induced mitochondrial membrane-potential dissipation does not necessarily require cytosolic oxidative stress: studies using rhodamine-123 fluorescence unquenching", Toxicol Sci, 77, pp.299~306 (2004)
- Chakraborty D, "Antihyperglycemic potentials of a threatened plant, Helonias dioica: antioxidative stress responses and the signaling cascade", Exp Biol Med, 237, pp.64~76 (2012)
- Chen Y, "Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species", J Cell Sci, 120, pp.4155~4166 (2007)
- Denning MF, "Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase C", Cell Death Differ, 9, pp.40~52 (2002)
- Guo W, "Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota", Cancer Res, 68, pp.7403~7408 (2008)
- Jemal A, "Cancer statistics", CA Cancer J Clin, 55, pp.10~30 (2005)
- Jurgensmeier JM, "Bax directly induces release of cytochrome c from isolated mitochondria", Proc Natl Acad Sci USA, 95, pp.4997~5002 (1998)
- Kim YM, "Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms", J Biol Chem, 272, pp.31138~31148 (1997)
- pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway, "Cancer Lett", 2009, 27~33
- Kroemer G, "Mitochondrial control of cell death", Nat Med, 6, pp.513~519 (2000)
- Li P, "Cytochrome c and dATP-dependent formation of Apaf-1", caspase-9 complex initiates an apoptotic protease cascade, 1997, pp.91, 479~489
- Ling YH, "Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells", J Biol Chem, 278, pp.33714~33723 (2003)
- Misra R, "Cancer nanotechnology: application of nanotechnology in cancer therapy", Drug Discov Today, 15, pp.842~850 (2010)
- Morley N, "UVA-induced apoptosis studied by the new apo", necro- comet assay which distinguishes viable, apoptotic and necrotic cells, 2006, pp.21, 105~114
- Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
- Rostock M, "Classical homeopathy in the treatment of cancer patients--a prospective observational study of two independent cohorts", BMC Cancer, 11, pp.19~ (2011)
- Samali A, "Apoptosis -- the story so far....", Experientia, 52, pp.933~941 (1996)
- Staunton MJ, "Apoptosis: basic concepts and potential significance in human cancer", Arc Pathol Lab Med, 122, pp.310~319 (1998)
- Su CC, "Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3", Anticancer Res, 26, pp.4379~4389 (2006)
- Susin SA, "Mitochondria as regulators of apoptosis: doubt no more", Biochim Biophys Acta, 1366, pp.151~165 (1998)
- Tan S, "The regulation of reactive oxygen species production during programmed cell death", J Cell Biol, 141, pp.1423~1432 (1998)
- Umehara K, "Studies on differentiation inducers. IV. Pregnane derivatives from condurango cortex", Chem Pharm Bull, 42, pp.611~616 (1994)
- Wang R, "Traditional medicines used in differentiation therapy of myeloid leukemia", Asian J Trad Med, pp.1~10 (2004)
- Whitehead CM, "Exisulind-induced apoptosis in a non-small cell lung cancer orthotopic lung tumor model augments docetaxel treatment and contributes to increased survival", Mol Can Ther, 2, pp.479~488 (2003)
- White A, "Life, death, and the pursuit of apoptosis", Genes Dev, 10, pp.1~15 (1996)
- pyrene 7, 8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions, "Chem Res Toxicol", 2000, 1046~1050
- Yeh CT, "Effect of sulforaphane on metallothionein expression and induction of apoptosis in humanhepatoma HepG2 cells", Carcinogenesis, 26, pp.2138~2140 (2005)